Biogen Inc (BIIB)

Index:

Nasdaq 100

$ 209.83
   
  • Change Today:
    $-0.82
  • 52 Week High: $216.28
  • 52 Week Low: $132.22
  • Currency: US Dollars
  • Shares Issued: 146.80m
  • Volume: 554,816
  • Market Cap: $30,803m
  • RiskGrade: 259

Latest ShareCast News

Biogen to buy Apellis Pharmaceuticals in $5.6bn deal

By Michele Maatouk

Date: Tuesday 31 Mar 2026

(Sharecast News) - Shares in Apellis Pharmaceuticals rocketed on Tuesday after it agreed to be bought by Biogen in a $5.6bn deal.

Biogen ups forecasts despite weak Alzheimer's drug sales

By Abigail Townsend

Date: Wednesday 20 Oct 2021

(Sharecast News) - Biogen raised its full-year earnings guidance on Wednesday, despite weak sales of breakthrough Alzheimer's drug Aduhelm.

Biogen shares soar as FDA approves Alzheimer's drug

By Abigail Townsend

Date: Tuesday 08 Jun 2021

(Sharecast News) - Shares in Biogen closed nearly 40% higher after the biotech's breakthrough Alzheimer's drug received regulatory approval in the US.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Biogen Inc Market Data

Currency US Dollars
Share Price $ 209.83
Change Today $ -0.82
% Change -0.39 %
52 Week High $216.28
52 Week Low $132.22
Volume 554,816
Shares Issued 146.80m
Market Cap $30,803m
RiskGrade 259

Trades for 14-Aug-2026

Time Volume / Share Price
16:00 128,233 @ $209.83
15:59 100 @ $209.79
15:59 100 @ $209.78
15:59 100 @ $209.75
15:59 200 @ $209.75

Top of Page